These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 9344848
21. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. Pezet A, Favre H, Kelly PA, Edery M. J Biol Chem; 1999 Aug 27; 274(35):24497-502. PubMed ID: 10455112 [Abstract] [Full Text] [Related]
22. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA. EMBO J; 1999 Jan 15; 18(2):375-85. PubMed ID: 9889194 [Abstract] [Full Text] [Related]
23. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. Ohya Ki, Kajigaya S, Yamashita Y, Miyazato A, Hatake K, Miura Y, Ikeda U, Shimada K, Ozawa K, Mano H. J Biol Chem; 1997 Oct 24; 272(43):27178-82. PubMed ID: 9341160 [Abstract] [Full Text] [Related]
24. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. Bousquet C, Susini C, Melmed S. J Clin Invest; 1999 Nov 24; 104(9):1277-85. PubMed ID: 10545526 [Abstract] [Full Text] [Related]
25. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells. Monni R, Santos SC, Mauchauffe M, Berger R, Ghysdael J, Gouilleux F, Gisselbrecht S, Bernard O, Penard-Lacronique V. Oncogene; 2001 Feb 15; 20(7):849-58. PubMed ID: 11314018 [Abstract] [Full Text] [Related]
26. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A. J Exp Med; 2001 Feb 19; 193(4):471-81. PubMed ID: 11181699 [Abstract] [Full Text] [Related]
27. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, Yamamoto H, Matsumoto T, Saito H, Hosoe S, Kishimoto T. Biochem Biophys Res Commun; 1997 Aug 08; 237(1):79-83. PubMed ID: 9266833 [Abstract] [Full Text] [Related]
28. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. Yoshimura A, Ichihara M, Kinjyo I, Moriyama M, Copeland NG, Gilbert DJ, Jenkins NA, Hara T, Miyajima A. EMBO J; 1996 Mar 01; 15(5):1055-63. PubMed ID: 8605875 [Abstract] [Full Text] [Related]
29. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A. EMBO J; 1995 Jun 15; 14(12):2816-26. PubMed ID: 7796808 [Abstract] [Full Text] [Related]
30. The CIS/SOCS proteins: a family of cytokine-inducible regulators of signaling. Gisselbrecht S. Eur Cytokine Netw; 1999 Dec 15; 10(4):463-70. PubMed ID: 10586112 [Abstract] [Full Text] [Related]
31. The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons. Sakamoto H, Kinjyo I, Yoshimura A. Leuk Lymphoma; 2000 Jun 15; 38(1-2):49-58. PubMed ID: 10811447 [Abstract] [Full Text] [Related]
32. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Sadowski CL, Wheeler TT, Wang LH, Sadowski HB. Endocrinology; 2001 Sep 15; 142(9):3890-900. PubMed ID: 11517167 [Abstract] [Full Text] [Related]
33. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, Kitamura T, Kato H, Nakayama Ki, Yoshimura A. J Biol Chem; 2001 Apr 20; 276(16):12530-8. PubMed ID: 11278610 [Abstract] [Full Text] [Related]
34. A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1). Giordanetto F, Kroemer RT. Protein Eng; 2003 Feb 20; 16(2):115-24. PubMed ID: 12676980 [Abstract] [Full Text] [Related]
35. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N. Mol Endocrinol; 1999 Nov 20; 13(11):1832-43. PubMed ID: 10551777 [Abstract] [Full Text] [Related]
36. Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Raccurt M, Tam SP, Lau P, Mertani HC, Lambert A, Garcia-Caballero T, Li H, Brown RJ, McGuckin MA, Morel G, Waters MJ. Br J Cancer; 2003 Aug 04; 89(3):524-32. PubMed ID: 12888825 [Abstract] [Full Text] [Related]
37. HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells. Oda T, Muramatsu MA, Isogai T, Masuho Y, Asano S, Yamashita T. Biochem Biophys Res Commun; 2001 Nov 16; 288(5):1078-86. PubMed ID: 11700021 [Abstract] [Full Text] [Related]
38. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Liebermann DA, Hoffman B. Stem Cells; 1994 Jul 16; 12(4):352-69. PubMed ID: 7951003 [Abstract] [Full Text] [Related]
39. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Kurzer JH, Saharinen P, Silvennoinen O, Carter-Su C. Mol Cell Biol; 2006 Sep 16; 26(17):6381-94. PubMed ID: 16914724 [Abstract] [Full Text] [Related]
40. Kinase activation through dimerization by human SH2-B. Nishi M, Werner ED, Oh BC, Frantz JD, Dhe-Paganon S, Hansen L, Lee J, Shoelson SE. Mol Cell Biol; 2005 Apr 16; 25(7):2607-21. PubMed ID: 15767667 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]